- Home
- CCCC vs MIY Comparison
CCCC vs MIY Comparison
Compare CCCC & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- MIY
- Stock Information
- Founded
- CCCC 2015
- MIY 1992
- Country
- CCCC United States
- MIY United States
- Employees
- CCCC N/A
- MIY N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- MIY Investment Bankers/Brokers/Service
- Sector
- CCCC Health Care
- MIY Finance
- Exchange
- CCCC Nasdaq
- MIY Nasdaq
- Market Cap
- CCCC 244.9M
- MIY 340.0M
- IPO Year
- CCCC 2020
- MIY N/A
- Fundamental
- Price
- CCCC $3.64
- MIY $11.67
- Analyst Decision
- CCCC Buy
- MIY
- Analyst Count
- CCCC 6
- MIY 0
- Target Price
- CCCC $10.67
- MIY N/A
- AVG Volume (30 Days)
- CCCC 1.9M
- MIY 56.8K
- Earning Date
- CCCC 02-20-2025
- MIY 01-01-0001
- Dividend Yield
- CCCC N/A
- MIY 3.98%
- EPS Growth
- CCCC N/A
- MIY N/A
- EPS
- CCCC N/A
- MIY N/A
- Revenue
- CCCC $33,668,000.00
- MIY N/A
- Revenue This Year
- CCCC $75.79
- MIY N/A
- Revenue Next Year
- CCCC N/A
- MIY N/A
- P/E Ratio
- CCCC N/A
- MIY N/A
- Revenue Growth
- CCCC 65.45
- MIY N/A
- 52 Week Low
- CCCC $3.25
- MIY $9.45
- 52 Week High
- CCCC $11.88
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- CCCC 41.72
- MIY 60.53
- Support Level
- CCCC $3.25
- MIY $11.39
- Resistance Level
- CCCC $3.84
- MIY $11.67
- Average True Range (ATR)
- CCCC 0.20
- MIY 0.14
- MACD
- CCCC -0.01
- MIY 0.04
- Stochastic Oscillator
- CCCC 29.49
- MIY 83.33
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from federal and Michigan income taxes.